AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
What is the latest Revenue of AJANTA PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹4,209 Cr |
Mar2023 | ₹3,743 Cr |
Mar2022 | ₹3,341 Cr |
Mar2021 | ₹2,890 Cr |
Mar2020 | ₹2,588 Cr |
How is Revenue of AJANTA PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹4,209 Cr | 12.45 | |
Mar2023 | ₹3,743 Cr | 12.02 | |
Mar2022 | ₹3,341 Cr | 15.62 | |
Mar2021 | ₹2,890 Cr | 11.66 | |
Mar2020 | ₹2,588 Cr | - |
Compare Revenue of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹31,123.8 Cr | -4.8% | -2.9% | 9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,188.0 Cr | -1.5% | 4.6% | 3% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,074.0 Cr | -4.8% | -3.2% | 40.7% | Stock Analytics | |
CIPLA | ₹115,768.0 Cr | -1.3% | -1.9% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,809.0 Cr | 1.1% | 6.1% | 27.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,503.5 Cr | -3.6% | -2.7% | -11.4% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -4.8% |
-2.9% |
9.5% |
SENSEX | -2.4% |
0.7% |
0.5% |
You may also like the below Video Courses